Pharmaceuticals

Oligonucleotide Therapy Market Outlook 2026–2030 Driven By Growth Factors And Projections

May 1, 2026May 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Oligonucleotide Therapy Market During The Forecast Period?

The oligonucleotide therapy market has experienced significant expansion recently. It is projected to increase from $6.2 billion in 2025 to $6.91 billion in 2026, driven by a compound annual growth rate (CAGR) of 11.5%. This historical growth can be linked to several factors, including heightened research and development in oligonucleotide synthesis, the rising demand for targeted therapies, improvements in molecular biology techniques, an increase in chronic and genetic diseases, and the early adoption of antisense and aptamer technologies.

The oligonucleotide therapy market is set for substantial growth over the next few years. It is forecast to reach $10.87 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.0%. This expansion during the forecast period can be attributed to the increasing scope of personalized medicine, the integration of artificial intelligence in drug discovery, the rise of precision medicine initiatives, the creation of next-generation delivery platforms, and a surge in collaborations between biotech and pharmaceutical firms. Prominent trends for the same forecast period encompass targeted gene regulation, therapeutics based on RNA interference, the progression of personalized medicine, advanced drug delivery systems, and nucleic acid-based diagnostics.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3398&type=smp

What Major Factors Are Driving The Oligonucleotide Therapy Market Forward?

Government-led initiatives for research and development within the healthcare sector are anticipated to fuel the future expansion of the oligonucleotide therapy market. These government initiatives refer to specific actions, programs, policies, or projects undertaken by governmental authorities at various levels, including local, regional, national, or international, to address particular issues, achieve certain goals, or generate positive societal changes. A number of government authorities are currently launching diverse healthcare initiatives to support various aspects, among them oligonucleotide therapy. For instance, according to the American Medical Association, a US-based professional organization, in April 2025, U.S. health spending in 2023 rose by 7.5% to $4.9 trillion, or $14,570 per capita. This growth surpassed the 4.6% increase observed in 2022. Thus, the government initiatives dedicated to healthcare research and development are indeed driving the growth of the oligonucleotide therapy market.

What Are The Main Segments Within The Oligonucleotide Therapy Market Segment Structure?

The oligonucleotide therapy market covered in this report is segmented –

1) By Type: Antisense Oligonucleotide, Aptamer, Other Types

2) By Application: Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Other End-User

3) By End User: Hospitals, Research Institutes

Subsegments:

1) By Antisense Oligonucleotide: RNA-Targeted Antisense Oligonucleotides, DNA-Targeted Antisense Oligonucleotides, Chemically Modified Antisense Oligonucleotides

2) By Aptamer: DNA Aptamers, RNA Aptamers, Small Molecule Aptamers

3) By Other Types: siRNA (Small Interfering RNA), miRNA (Micro RNA), DNAzyme And Ribozymes, Synthetic Oligonucleotides For Gene Editing

What Trends Are Affecting The Direction Of The Oligonucleotide Therapy Market?

Leading companies in the oligonucleotide therapy market are concentrating on creating advanced treatments, including gene therapies, to tackle the root causes of genetic diseases, improve patient results, and alleviate the long-term treatment burden. Gene therapies are cutting-edge medical interventions designed to introduce a functional gene into a patient’s cells to make up for a non-functional or mutated one. For instance, in June 2023, Sarepta Therapeutics Inc., a US-based biotechnology company, obtained Food and Drug administration (FDA) approval for ELEVIDYS. This product represents a first-of-its-kind gene therapy specifically for ambulatory pediatric patients with Duchenne muscular dystrophy (DMD). It functions as a single-dose treatment engineered to deliver a gene that codes for a shortened functional form of dystrophin to muscle cells, aiming to stop or reverse the disease’s advancement.

Who Are The Companies Participating In The Oligonucleotide Therapy Market?

Major companies operating in the oligonucleotide therapy market are Pfizer Inc., GlaxoSmithKline plc, Gilead Sciences Inc., Biogen Inc., Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Ionis Pharmaceuticals Inc., Akcea Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., SomaGenics Inc., Wave Life Sciences Ltd., Exicure Inc., Avidity Biosciences Inc., Miragen Therapeutics Inc., ProQR Therapeutics NV, Regulus Therapeutics Inc., Kastle Therapeutics LLC, Santaris Pharma A/S, InteRNA Technologies B.V., Evox Therapeutics Ltd., PepGen Ltd.

Get The Full Oligonucleotide Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Which Region Holds The Highest Market Share In The Oligonucleotide Therapy Market?

North America was the largest region in the oligonucleotide therapy market in 2025. The regions covered in the oligonucleotide therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Oligonucleotide Therapy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Browse Through More Reports Similar to the Global Oligonucleotide Therapy Market 2026, By The Business Research Company

Oligonucleotides Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Oligonucleotide Synthesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report

Nucleic Acid Based Gene Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795